发明名称 |
VACCINES AGAINST HEPATITIS B VIRUS |
摘要 |
A pharmaceutical composition comprising at least two peptides of from 15 to 60 amino acids in length, selected from peptides comprising a sequence of at least 15 contiguous amino acids of one of the sequences shown in SEQ ID NOs: 1 to 4 or of a sequence having at least 80% identity to one of the sequences shown in SEQ ID NOs: to 4, wherein each peptide comprises at least one CD8+ T-cell epitope and/or at least one CD4+ T-cell epitope and wherein each peptide elicits a response in peripheral blood mononuclear cells (PBMC) from at least one chronically infected HBV individual in an 10 in vitroassay. |
申请公布号 |
EP2935313(A1) |
申请公布日期 |
2015.10.28 |
申请号 |
EP20130814593 |
申请日期 |
2013.12.20 |
申请人 |
VAXIN UK LIMITED |
发明人 |
GEORGES, BERTRAND VICTOR GILBERT;BROWN, CARLTON BRADLEY |
分类号 |
C07K14/02;A61K39/12;A61K39/29;A61P35/00;C12N7/00 |
主分类号 |
C07K14/02 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|